Knowledge

Coley's toxins

Source đź“ť

105: 484:
challenge or modulation are not specific enough (not targeted enough), present too many harms, and do not work consistently enough to bring benefits to most patients, being dependent on idiotypic molecular factors (which were not understood at all when the therapies were first developed and which even today are still not easy for immunotherapy designers to deal with).
302:
are either in "repair mode", furthering the growing of cancer, or in "defense mode", destroying cancer. However, macrophages are in "defense mode" only if there is some recognized enemy. As cancer tissue is not recognized as enemy (but as normal body tissue), there is a need to bring more macrophages
474:
and William Coley as colleagues at the same institution. Hall explains that the aspects of Coley's work that were scientifically underpowered—the anecdotal emphasis, the lack of a standardized formula for the toxins preparations, the lack of methodologically rigorous clinical trials, and (relatedly)
239:
The so-called Coley's toxins were used against different types of cancer from the year 1893 through the year 1963. Within the preparation's first decade, it was changed from an unfiltered mixture of killed bacteria to a porcelain-filtered mixture, which reduced the adverse effect profile. From 1923
193:
wounds were left open to facilitate the development of infection. Throughout the time period, physicians reported successful treatment of cancer by exposing the tumor to infection including the report of French physician Dussosoy who covered an ulcerated breast carcinoma with gangrenous discharge
483:
as alternative medicine is flawed, given what humanity now knows about molecular biology that was not known when these older therapies were tried: Even if certain kinds of immune challenge or immunomodulation can produce desirable immunotherapeutic effects, these crude methods of inducing such
470:, Coley's toxins were opposed by the medical establishment despite his reports of good results, because his reports were not believed to be credible. Hall (1997) extensively explores the issue; one of the lenses through which Hall explores it is the decades-long, complicated relationship of 184:
by a poultice, followed by incision, to facilitate the development of infection in the desired location and cause regression of the tumors. In 13th century, St. Peregrine experienced spontaneous regression of tumor, after the tumor became infected. In the 18th and 19th centuries, deliberate
475:
the problem of poor replicability—led many scientists to dismiss all use of Coley's toxins as mere hogwash. Although the truth was more complex than that dismissal recognized, it is a fact that the toxins never made it to the stage of a safe and effective medication, and today their use as
161:, "available scientific evidence does not currently support claims that Coley's toxins can treat or prevent cancer". People with cancer who take Coley's toxins alongside conventional cancer treatments, or who use it as a substitute for those treatments, risk seriously harming their health. 216:
Frustrated by this case, Coley's subsequent research led him to announce evidence of the apparent relationship between infection and cancer regression, which he published in 1891. His initial attempts at deliberate infection were mixed, but in 1893 he began combining
653: 416:
Some specialized medical doctors in Germany apply Coley's toxins to patients. They can do so legally because, in Germany, unapproved medications may be produced, although they may not be sold or given away. Physicians can go to special
194:
soaked cloth, resulting in disappearance of tumor. Observations of a relationship between infection and cancer regression date back to at least the 18th century. More specifically, observations of an apparent relationship between
1614: 1021: 381:(DC), leading to the activation of anergic T cells, possibly accomplished through a second process, where physical damage to cancer cells leads to a sudden supply of cancer antigens to the dendritic cell population. 661: 389:
A private biotech company, Coley Pharmaceutical Group, has conducted clinical trials using genetic sequences which may have contributed to Coley's toxin's effectiveness, and was acquired by
1611: 1029: 508: 365:
from the patient) is the active agent of Coley's toxins. This hypothesis is supported by the fact that streptokinase has been associated with successful treatment of
279: 248:. Hall (1997) explains that the versions used by Coley himself were custom-compounded, although the formula for the preparation was never standardized. 1050:
Coley WB. The treatment of malignant tumors by repeated inoculations of Erysipelas, with a report of ten original cases. Am J Med Sci 1893;105:487–511.
421:
and produce Coley's toxins there using their own hands. Coley's toxins may still be applied by a licensed medical doctor, because in Germany there is "
431:"), the legal right to apply whichever therapy a physician considers to be appropriate in the light of their medical knowledge. For example, Dr 435:
used several unconventional and controversial treatments, including Coley's toxins, for cancer patients in the second half of the 20th century.
1642: 1470: 570:
Taniguchi Y, Nishizawa T, Kouhchi C, et al. (2006). "Identification and characterization of lipopolysaccharide in acetic acid bacteria".
377:
A robust fever, which occurs in response to Coley fluid, generates inflammatory factors with co-stimulatory activity, which activate resting
1174: 847: 1132: 632: 144: 1394:
Hussein EA, el Dorri A (1993). "Intra-arterial streptokinase as adjuvant therapy for complicated Buerger's disease: early trials".
393:
in January 2008. In addition, the Waisbren Clinic in Wisconsin reports they have used Coley's toxin to treat patients since 1972.
232:
Coley published the results of his work as a case series, making it difficult to interpret them with confidence. According to the
1422: 91:
There is no evidence that Coley's toxins have any effectiveness in treating cancer, and use of them risks causing serious harm.
331:
which causes fever. The resulting fever from the lipopolysaccharide is thought to increase lymphocyte activity and boosts
1494: 408:
are interested in modern versions of Coley's toxins; Pfizer has acquired the Coley Pharmaceutical Group, set up in 1997
260: 74: 332: 236:, "more research would be needed to determine what benefit, if any, this therapy might have for people with cancer". 397:
are generally not available where approval or licence is required (in particular in the United States and Germany).
366: 126: 115: 471: 256: 598:
Pick, Thomas Pickering, "Surgery," Longmans, Green and Company, 1899, Pages 250–251. Retrieved August 3, 2010.
1622: 1025: 233: 210: 692:"Spontaneous regression of tumour and the role of microbial infection – possibilities for cancer treatment" 447: 357: 219: 122: 55: 1599: 675:
Cann; et al. (2003). "Dr William Coley and tumour regression: A place in history or in the future".
213:, who later indicated that her death was what first motivated his subsequent funding of cancer research. 1637: 1446: 205:
Coley started his investigations after the death of one of his first patients, Elizabeth Dashiell, from
173:
for the treatment of cancer has been utilized throughout history, with the earliest cases going back to
1247: 1148: 1080: 527:
Thotathil Z, Jameson MB (2007). "Early experience with novel immunomodulators for cancer treatment".
498: 476: 451: 85: 1594: 225: 70: 61: 1376: 1333: 657: 552: 328: 229:, based upon research from G.H. Roger indicating that this combination led to greater virulence. 158: 1104: 1556: 1403: 1368: 1325: 1284: 1226: 1128: 1109: 994: 920: 821: 772: 721: 628: 579: 544: 1172: 1081:"Coley's Toxins – The First Century Townsend Letter for Doctors and Patients – Find Articles" 845: 1546: 1360: 1315: 1276: 1216: 1208: 984: 938: 912: 811: 803: 762: 752: 711: 703: 536: 84:
Their use in the late nineteenth and early 20th centuries represented a precursor to modern
1618: 1178: 1060: 851: 458:
is not the same type of treatment, although sometimes incorrectly called "fever therapy".
428: 1481: 1235: 423: 1551: 1534: 1221: 1196: 989: 972: 816: 791: 767: 740: 716: 691: 503: 480: 405: 378: 340: 319:. Thus, fever is seen as a precondition for a therapy using Coley's Toxins to succeed. 264: 1364: 1212: 869: 596: 1631: 1320: 1303: 621: 493: 455: 443: 352: 316: 245: 199: 170: 66: 1380: 1337: 1304:"Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer?" 556: 267:. Since then, several small clinical trials have been conducted with mixed results. 1535:"The Toxins of William B. Coley and the Treatment of Bone and Soft-Tissue Sarcomas" 973:"The Toxins of William B. Coley and the Treatment of Bone and Soft-Tissue Sarcomas" 432: 418: 312: 17: 327:
One of the agents in Coley's Toxin that is thought to be biologically active is a
1280: 707: 88:, although at that time their mechanism of action was not completely understood. 1482:
news-medical.net: Pfizer to acquire Coley Pharmaceutical Group, 19 November 2007
1471:
New York Times: article on Pfizer and Coley Pharmaceutical Group, 5 October 2005
916: 362: 315:, real fever not only means heating of the body but also higher activity of the 278:. However, production ceased by 1990 because of a lack of re-approval by German 252: 241: 807: 540: 1509: 299: 195: 27:
Bacterial toxins formerly used in a precursor analogue of modern immunotherapy
1197:"Dr William Coley and tumour regression: a place in history or in the future" 270:
Coley's toxins were also produced by the small German pharmaceutical company
757: 304: 186: 1560: 1372: 1329: 1288: 1230: 998: 825: 792:"Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations" 776: 725: 583: 548: 290:
There were multiple rationales proposed for how Coley's toxins might work.
1407: 924: 53:) is a mixture containing toxins filtered from killed bacteria of species 181: 202:, in his capacity as a physician, recorded such a relationship in 1884. 206: 190: 1125:
Can bacteria cause cancer?: alternative medicine confronts big science
77:
who developed the mixture in the late 19th century as a treatment for
893:
W. Busch. Einfluβ von Erysipel. Berliner Klin Wschr 1866. 3: 245–246.
401: 390: 78: 858:, Cancer Immunol Immunother 2001) 50: 391–396 10.1007/s002620100216 1581: 308: 1450: 741:"Immunity over inability: The spontaneous regression of cancer" 259:
of 1962, Coley's toxins were assigned "new drug" status by the
98: 623:
A commotion in the blood: life, death, and the immune system
1166: 1164: 1011:
Roger, G.H. Séances et Mém Soc de Biol Paris 1890;2:573–580
903:
Gresser I (1987). "A. Chekhov, M.D., and Coley's toxins".
1267:
Tsung K, Norton JA (2006). "Lessons from Coley's Toxin".
244:
was the only commercial source of Coley's toxins in the
1113:, published February 18, 2008. Accessed March 26, 2008. 263:(FDA), making it illegal to prescribe them outside of 125:. Please help to ensure that disputed statements are 198:
and remission of cancer predate Coley. For example,
1195:Hoption Cann S, van Netten J, van Netten C (2003). 1127:. New York: New York University Press. p. 11. 614: 612: 610: 608: 606: 604: 450:). This term was introduced by E. Göhring in 1985. 620: 339:reported that the active agent was thought to be 1185:, British Journal of Cancer (2005) 92, 421 – 425 509:List of unproven and disproven cancer treatments 1584:, William B. Coley, Surgeon-in-Chief, 1925-1933 280:Federal Institute for Drugs and Medical Devices 654:"What is Coley's toxins treatment for cancer?" 8: 868:Kleef, Ralf; Hager, E. Dieter (2006-09-15). 307:. The simulated infection results in a real 189:of tumors was a standard treatment, whereby 961:Coley WB. Annals of Surgery 1891;14:199–200 479:is clearly flawed for the same reason that 209:. Dashiell was a close childhood friend of 839: 837: 835: 1550: 1495:"Fiebertherapie bei Krebs vernachlässigt" 1319: 1220: 988: 815: 766: 756: 715: 145:Learn how and when to remove this message 1085:Townsend Letter for Doctors and Patients 355:(produced by killed bacteria of species 121:Relevant discussion may be found on the 1351:Haux J (2001). "Infection and cancer". 529:Expert Opinion on Investigational Drugs 519: 648: 646: 644: 1423:"Cancer and the bacterial connection" 446:) or better "Aktive Fiebertherapie" ( 323:Tumor necrosis factor and interleukin 303:into "defense mode" by simulating an 180:. Egyptian physician Imhotep treated 7: 438:This kind of therapy is offered as 25: 1061:"Coley's Toxins Cancer Treatment" 1028:. 1 November 2008. Archived from 690:Kucerova P, Cervinkova M (2016). 1321:10.1111/j.1538-7836.2005.01110.x 1302:Zacharski L, Sukhatme V (2005). 660:. 22 August 2012. Archived from 103: 1421:Borrell, Brendan (2008-02-18). 1213:10.1093/postgradmedj/79.938.672 856:Fever and cancer in perspective 466:According to an article in the 351:Another hypothesis argues that 1248:"Proposed Mechanism of Action" 274:and sold under the trade name 1: 1643:Alternative cancer treatments 1447:"Waisbren Clinic – Home Page" 1365:10.1016/S0140-6736(01)05369-7 174: 1582:Hospital for Special Surgery 1539:The Iowa Orthopaedic Journal 1281:10.1016/j.suronc.2006.05.002 977:The Iowa Orthopaedic Journal 870:"Fever, Pyrogens and cancer" 708:10.1097/CAD.0000000000000337 677:Postgraduate Medical Journal 261:Food and Drug Administration 75:Hospital for Special Surgery 917:10.1056/NEJM198708133170716 335:(TNF). Tsung and Norton in 1659: 1600:Coley Pharmaceutical Group 939:"A Commotion in the Blood" 808:10.7453/gahmj.2012.1.1.016 541:10.1517/13543784.16.9.1391 367:thromboangiitis obliterans 298:One rationale argues that 619:Hall, Stephen K. (1997). 257:Kefauver Harris Amendment 1149:"History and Background" 874:Landes Bioscience: Curie 627:. New York: Henry Holt. 1623:American Cancer Society 1183:Fever therapy revisited 1123:Hess, J David. (1997). 1026:American Cancer Society 758:10.4103/0976-9668.82318 468:Iowa Orthopedic Journal 234:American Cancer Society 211:John D. Rockefeller Jr. 51:mixed bacterial vaccine 1508:: 3377. Archived from 400:Drug makers including 358:Streptococcus pyogenes 220:Streptococcus pyogenes 56:Streptococcus pyogenes 1533:McCarthy, EF (2006). 1427:The Los Angeles Times 1396:International Surgery 1105:Germs As A Tumor Foe? 462:Professional politics 333:tumor necrosis factor 1595:MBVax Bioscience Inc 971:McCarthy EF (2006). 664:on 17 December 2019. 499:Cancer immunotherapy 477:alternative medicine 452:Hyperthermia therapy 448:active fever therapy 255:controversy and the 114:factual accuracy is 86:cancer immunotherapy 1493:Göhring, E (1985). 876:. Landes Bioscience 796:Glob Adv Health Med 343:, rather than TNF. 251:In the wake of the 226:Serratia marcescens 71:surgical oncologist 62:Serratia marcescens 18:Coley's Toxins 1617:2015-04-26 at the 1606:Scientific reviews 1177:2009-12-11 at the 943:The New York Times 850:2009-12-11 at the 790:Kienle GS (2012). 745:J Nat Sci Biol Med 658:Cancer Research UK 329:lipopolysaccharide 159:Cancer Research UK 1269:Surgical Oncology 1110:Los Angeles Times 578:(6A): 3997–4002. 337:Surgical Oncology 155: 154: 147: 16:(Redirected from 1650: 1565: 1564: 1554: 1530: 1524: 1523: 1521: 1520: 1514: 1499: 1490: 1484: 1479: 1473: 1468: 1462: 1461: 1459: 1458: 1449:. Archived from 1443: 1437: 1436: 1434: 1433: 1418: 1412: 1411: 1391: 1385: 1384: 1348: 1342: 1341: 1323: 1308:J Thromb Haemost 1299: 1293: 1292: 1264: 1258: 1257: 1255: 1254: 1244: 1238: 1234: 1224: 1192: 1186: 1168: 1159: 1158: 1156: 1155: 1145: 1139: 1138: 1120: 1114: 1102: 1096: 1095: 1093: 1092: 1077: 1071: 1070: 1068: 1067: 1057: 1051: 1048: 1042: 1041: 1039: 1037: 1032:on 26 April 2015 1018: 1012: 1009: 1003: 1002: 992: 968: 962: 959: 953: 952: 950: 949: 935: 929: 928: 900: 894: 891: 885: 884: 882: 881: 865: 859: 841: 830: 829: 819: 787: 781: 780: 770: 760: 739:Jessy T (2011). 736: 730: 729: 719: 696:Anticancer Drugs 687: 681: 680: 672: 666: 665: 650: 639: 638: 626: 616: 599: 594: 588: 587: 567: 561: 560: 524: 440:"Fiebertherapie" 424:Therapiefreiheit 179: 176: 150: 143: 139: 136: 130: 127:reliably sourced 107: 106: 99: 21: 1658: 1657: 1653: 1652: 1651: 1649: 1648: 1647: 1628: 1627: 1619:Wayback Machine 1608: 1591: 1578: 1573: 1568: 1532: 1531: 1527: 1518: 1516: 1512: 1497: 1492: 1491: 1487: 1480: 1476: 1469: 1465: 1456: 1454: 1445: 1444: 1440: 1431: 1429: 1420: 1419: 1415: 1393: 1392: 1388: 1359:(9276): 155–6. 1350: 1349: 1345: 1301: 1300: 1296: 1266: 1265: 1261: 1252: 1250: 1246: 1245: 1241: 1207:(938): 672–80. 1194: 1193: 1189: 1179:Wayback Machine 1169: 1162: 1153: 1151: 1147: 1146: 1142: 1135: 1122: 1121: 1117: 1103: 1099: 1090: 1088: 1079: 1078: 1074: 1065: 1063: 1059: 1058: 1054: 1049: 1045: 1035: 1033: 1020: 1019: 1015: 1010: 1006: 970: 969: 965: 960: 956: 947: 945: 937: 936: 932: 905:N. Engl. J. Med 902: 901: 897: 892: 888: 879: 877: 867: 866: 862: 852:Wayback Machine 842: 833: 789: 788: 784: 738: 737: 733: 689: 688: 684: 674: 673: 669: 652: 651: 642: 635: 618: 617: 602: 595: 591: 569: 568: 564: 535:(9): 1391–403. 526: 525: 521: 517: 490: 464: 429:therapy freedom 414: 387: 379:dendritic cells 375: 373:Dendritic cells 349: 325: 296: 288: 265:clinical trials 177: 167: 151: 140: 134: 131: 120: 112:This article's 108: 104: 97: 39:Coley's vaccine 28: 23: 22: 15: 12: 11: 5: 1656: 1654: 1646: 1645: 1640: 1630: 1629: 1626: 1625: 1607: 1604: 1603: 1602: 1597: 1590: 1587: 1586: 1585: 1577: 1574: 1572: 1571:External links 1569: 1567: 1566: 1525: 1485: 1474: 1463: 1438: 1413: 1386: 1343: 1294: 1259: 1239: 1201:Postgrad Med J 1187: 1160: 1140: 1133: 1115: 1097: 1072: 1052: 1043: 1022:"Coley Toxins" 1013: 1004: 963: 954: 930: 895: 886: 860: 831: 782: 731: 682: 667: 640: 633: 600: 589: 572:Anticancer Res 562: 518: 516: 513: 512: 511: 506: 504:Cancer vaccine 501: 496: 489: 486: 481:malariotherapy 463: 460: 413: 410: 406:Sanofi-Aventis 395:Coley's toxins 386: 383: 374: 371: 361:together with 348: 345: 341:interleukin-12 324: 321: 295: 292: 287: 284: 178: 2600 BC 166: 163: 153: 152: 111: 109: 102: 96: 93: 65:, named after 31:Coley's toxins 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 1655: 1644: 1641: 1639: 1636: 1635: 1633: 1624: 1620: 1616: 1613: 1610: 1609: 1605: 1601: 1598: 1596: 1593: 1592: 1588: 1583: 1580: 1579: 1575: 1570: 1562: 1558: 1553: 1548: 1544: 1540: 1536: 1529: 1526: 1515:on 2014-05-17 1511: 1507: 1503: 1502:Ă„rztl. Praxis 1496: 1489: 1486: 1483: 1478: 1475: 1472: 1467: 1464: 1453:on 2007-10-12 1452: 1448: 1442: 1439: 1428: 1424: 1417: 1414: 1409: 1405: 1401: 1397: 1390: 1387: 1382: 1378: 1374: 1370: 1366: 1362: 1358: 1354: 1347: 1344: 1339: 1335: 1331: 1327: 1322: 1317: 1313: 1309: 1305: 1298: 1295: 1290: 1286: 1282: 1278: 1274: 1270: 1263: 1260: 1249: 1243: 1240: 1237: 1232: 1228: 1223: 1218: 1214: 1210: 1206: 1202: 1198: 1191: 1188: 1184: 1181: 1180: 1176: 1173: 1167: 1165: 1161: 1150: 1144: 1141: 1136: 1134:0-8147-3562-2 1130: 1126: 1119: 1116: 1112: 1111: 1106: 1101: 1098: 1086: 1082: 1076: 1073: 1062: 1056: 1053: 1047: 1044: 1031: 1027: 1023: 1017: 1014: 1008: 1005: 1000: 996: 991: 986: 982: 978: 974: 967: 964: 958: 955: 944: 940: 934: 931: 926: 922: 918: 914: 910: 906: 899: 896: 890: 887: 875: 871: 864: 861: 857: 854: 853: 849: 846: 840: 838: 836: 832: 827: 823: 818: 813: 809: 805: 802:(1): 92–100. 801: 797: 793: 786: 783: 778: 774: 769: 764: 759: 754: 750: 746: 742: 735: 732: 727: 723: 718: 713: 709: 705: 702:(4): 269–77. 701: 697: 693: 686: 683: 678: 671: 668: 663: 659: 655: 649: 647: 645: 641: 636: 634:0-8050-5841-9 630: 625: 624: 615: 613: 611: 609: 607: 605: 601: 597: 593: 590: 585: 581: 577: 573: 566: 563: 558: 554: 550: 546: 542: 538: 534: 530: 523: 520: 514: 510: 507: 505: 502: 500: 497: 495: 494:Immunotherapy 492: 491: 487: 485: 482: 478: 473: 469: 461: 459: 457: 456:thermotherapy 453: 449: 445: 444:fever therapy 441: 436: 434: 430: 426: 425: 420: 411: 409: 407: 403: 398: 396: 392: 384: 382: 380: 372: 370: 368: 364: 360: 359: 354: 353:streptokinase 347:Streptokinase 346: 344: 342: 338: 334: 330: 322: 320: 318: 317:immune system 314: 310: 306: 301: 293: 291: 285: 283: 281: 277: 273: 268: 266: 262: 258: 254: 249: 247: 246:United States 243: 237: 235: 230: 228: 227: 222: 221: 214: 212: 208: 203: 201: 200:Anton Chekhov 197: 192: 188: 183: 172: 171:immunotherapy 164: 162: 160: 157:According to 149: 146: 138: 135:November 2023 128: 124: 118: 117: 110: 101: 100: 94: 92: 89: 87: 82: 80: 76: 72: 68: 67:William Coley 64: 63: 58: 57: 52: 48: 47:Coley's fluid 44: 43:Coley vaccine 40: 36: 35:Coley's toxin 33:(also called 32: 19: 1638:Bacteriology 1612:Coley toxins 1542: 1538: 1528: 1517:. Retrieved 1510:the original 1505: 1501: 1488: 1477: 1466: 1455:. Retrieved 1451:the original 1441: 1430:. Retrieved 1426: 1416: 1399: 1395: 1389: 1356: 1352: 1346: 1314:(3): 424–7. 1311: 1307: 1297: 1272: 1268: 1262: 1251:. Retrieved 1242: 1204: 1200: 1190: 1182: 1171: 1170:Hobohm, U.: 1152:. Retrieved 1143: 1124: 1118: 1108: 1100: 1089:. Retrieved 1084: 1075: 1064:. Retrieved 1055: 1046: 1034:. Retrieved 1030:the original 1016: 1007: 980: 976: 966: 957: 946:. Retrieved 942: 933: 908: 904: 898: 889: 878:. Retrieved 873: 863: 855: 844: 843:Hobohm, U.: 799: 795: 785: 748: 744: 734: 699: 695: 685: 676: 670: 662:the original 622: 592: 575: 571: 565: 532: 528: 522: 467: 465: 439: 437: 433:Josef Issels 422: 419:laboratories 415: 399: 394: 388: 385:Availability 376: 356: 350: 336: 326: 313:hyperthermia 297: 289: 275: 271: 269: 250: 238: 231: 224: 218: 215: 204: 168: 156: 141: 132: 113: 90: 83: 60: 54: 50: 46: 42: 38: 34: 30: 29: 1621:, from the 1402:(1): 54–8. 1275:(1): 25–8. 1107:, from the 751:(1): 43–9. 472:James Ewing 363:plasminogen 300:macrophages 294:Macrophages 276:Vaccineurin 253:thalidomide 242:Parke-Davis 1632:Categories 1519:2014-05-16 1457:2007-11-10 1432:2008-02-17 1253:2007-11-10 1154:2007-11-10 1091:2007-11-10 1066:2023-04-11 948:2007-11-10 911:(7): 457. 880:2014-10-10 515:References 196:erysipelas 169:Bacterial 1589:Companies 1576:Hospitals 1545:: 154–8. 983:: 154–8. 311:. Unlike 305:infection 286:Rationale 272:SĂĽdmedica 187:infection 123:talk page 1615:Archived 1561:16789469 1381:26865958 1373:11469250 1338:37089721 1330:15748226 1289:16814541 1231:14707241 1175:Archived 1036:14 April 999:16789469 848:Archived 826:24278806 777:22470233 726:26813865 584:17195448 557:33668239 549:17714025 488:See also 191:surgical 116:disputed 95:Efficacy 1552:1888599 1408:8473086 1222:1742910 990:1888599 925:3302707 817:3833486 768:3312698 717:4777220 412:Germany 207:sarcoma 165:History 73:at the 1559:  1549:  1406:  1379:  1371:  1353:Lancet 1336:  1328:  1287:  1229:  1219:  1131:  1087:. 2004 997:  987:  923:  824:  814:  775:  765:  724:  714:  631:  582:  555:  547:  402:Pfizer 391:Pfizer 182:tumors 79:cancer 1513:(PDF) 1498:(PDF) 1377:S2CID 1334:S2CID 553:S2CID 309:fever 1557:PMID 1404:PMID 1369:PMID 1326:PMID 1285:PMID 1236:link 1227:PMID 1129:ISBN 1038:2014 995:PMID 921:PMID 822:PMID 773:PMID 722:PMID 629:ISBN 580:PMID 545:PMID 427:" (" 404:and 240:on, 223:and 69:, a 59:and 1547:PMC 1361:doi 1357:358 1316:doi 1277:doi 1217:PMC 1209:doi 985:PMC 913:doi 909:317 812:PMC 804:doi 763:PMC 753:doi 712:PMC 704:doi 537:doi 454:or 49:or 1634:: 1555:. 1543:26 1541:. 1537:. 1506:86 1504:. 1500:. 1425:. 1400:78 1398:. 1375:. 1367:. 1355:. 1332:. 1324:. 1310:. 1306:. 1283:. 1273:15 1271:. 1225:. 1215:. 1205:79 1203:. 1199:. 1163:^ 1083:. 1024:. 993:. 981:26 979:. 975:. 941:. 919:. 907:. 872:. 834:^ 820:. 810:. 798:. 794:. 771:. 761:. 747:. 743:. 720:. 710:. 700:27 698:. 694:. 656:. 643:^ 603:^ 576:26 574:. 551:. 543:. 533:16 531:. 369:. 282:. 175:c. 81:. 45:, 41:, 37:, 1563:. 1522:. 1460:. 1435:. 1410:. 1383:. 1363:: 1340:. 1318:: 1312:3 1291:. 1279:: 1256:. 1233:. 1211:: 1157:. 1137:. 1094:. 1069:. 1040:. 1001:. 951:. 927:. 915:: 883:. 828:. 806:: 800:1 779:. 755:: 749:2 728:. 706:: 679:. 637:. 586:. 559:. 539:: 442:( 148:) 142:( 137:) 133:( 129:. 119:. 20:)

Index

Coley's Toxins
Streptococcus pyogenes
Serratia marcescens
William Coley
surgical oncologist
Hospital for Special Surgery
cancer
cancer immunotherapy
disputed
talk page
reliably sourced
Learn how and when to remove this message
Cancer Research UK
immunotherapy
tumors
infection
surgical
erysipelas
Anton Chekhov
sarcoma
John D. Rockefeller Jr.
Streptococcus pyogenes
Serratia marcescens
American Cancer Society
Parke-Davis
United States
thalidomide
Kefauver Harris Amendment
Food and Drug Administration
clinical trials

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑